Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom
Michael P. Torrens-Spence, Chun‐ting Liu, Tomáš Pluskal, Yin Kwan Chung, Jing‐ke Weng
ACS Chemical Biology November 28, 2018 DOI: 10.1021/acschembio.8b00821 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Biochemical characterization with transcriptome sequencing and X-ray crystallography Peer reviewed |
|---|---|
| Population | Psilocybe cubensis |
| Topics | Psilocybin Serotonin |
| Keywords | Monoamine neurotransmitter Biosynthesis Biochemistry Calcium Mushroom bodies Stereochemistry |
| Citations | 40 |
| Key points | PcncAAAD is a noncanonical aromatic L-amino acid decarboxylase from Psilocybe cubensis that requires a calcium-binding C-terminal double-β-barrel domain for activity and substrate permissiveness toward L-tryptophan and other aromatic amino acids. |
Abstract
Aromatic l-amino acid decarboxylases (AAADs) are a phylogenetically diverse group of enzymes responsible for the decarboxylation of aromatic amino acid substrates into their corresponding aromatic arylalkylamines. AAADs have been extensively studied in mammals and plants as they catalyze the first step in the production of neurotransmitters and bioactive phytochemicals, respectively. Unlike mammals and plants, the hallucinogenic psilocybin mushroom Psilocybe cubensis reportedly employs an unrelated phosphatidylserine-decarboxylase-like enzyme to catalyze l-tryptophan decarboxylation, the first step in psilocybin biosynthesis. To explore the origin of this chemistry in psilocybin mushroom, we generated the first de novo transcriptomes of P. cubensis and investigated several putative l-tryptophan-decarboxylase-like enzymes. We report the biochemical characterization of a noncanonical AAAD from P. cubensis ( PcncAAAD) that exhibits substrate permissiveness toward l-phenylalanine, l-tyrosine, and l-tryptophan, as well as chloro-tryptophan derivatives. The crystal structure of PcncAAAD revealed the presence of a unique C-terminal appendage domain featuring a novel double-β-barrel fold. This domain is required for PcncAAAD activity and regulates catalytic rate and thermal stability through calcium binding. PcncAAAD likely plays a role in psilocybin production in P. cubensis and offers a new tool for metabolic engineering of aromatic-amino-acid-derived natural products.
Citations in the library
Cited by 15
- Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development. Fungal biology April 1, 2022
- Genetic Survey of Psilocybe Natural Products ChemBioChem May 18, 2022
- S‐Adenosyl‐l‐Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms ChemBioChem December 4, 2019
- Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis ChemBioChem November 3, 2022
- Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds Frontiers in Fungal Biology November 29, 2023
and 10 more in the library
Cites 11
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
- Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry November 15, 2006
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
and 6 more in the library